Implantation or Injectable Dosage Form New Animal Drugs; Spectinomycin Sulfate
other · Food and Drug Administration · Rule · Published 2007-06-06 · Effective 2007-06-06 · 72 FR 31177
Document
Document number
E7-10801
Federal Register citation
72 FR 31177
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-06-06
Effective date
2007-06-06
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Div. of Pfizer, Inc. The supplemental NADA provides for revising nomenclature for two bovine respiratory pathogens on labeling for spectinomycin sulfate injectable solution.